Cargando…
Prescribing Patterns and Treatment Adherence in Patients with Asthma During the COVID-19 Pandemic
BACKGROUND: The COVID-19 pandemic has witnessed a reduction in asthma exacerbations across the United Kingdom. Several factors may underpin this, including reduced transmission of seasonal viruses and improved adherence to inhaled corticosteroids (ICS). However, little is known about how ICS use has...
Autores principales: | Dhruve, Hetal, d’Ancona, Grainne, Holmes, Steven, Dhariwal, Jaideep, Nanzer, Alexandra M., Jackson, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487166/ https://www.ncbi.nlm.nih.gov/pubmed/34610490 http://dx.doi.org/10.1016/j.jaip.2021.09.032 |
Ejemplares similares
-
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices
por: Dhruve, Hetal, et al.
Publicado: (2022) -
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020) -
Improving adherence in chronic airways disease: are we doing it wrongly?
por: d'Ancona, Gráinne, et al.
Publicado: (2021) -
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020) -
Covid‐19 in the absence of eosinophils: The outcome of confirmed SARS‐COV‐2 infection whilst on treatment with benralizumab
por: Francis, Charles H. R., et al.
Publicado: (2022)